Browsing Tag
Curasight A/S
1 post
EMA clears Curasight’s uTREAT trial—will targeted radiopharma redefine brain cancer therapy?
Curasight wins EMA approval for its first uTREAT clinical trial in glioblastoma. Find out how its theranostic strategy could change brain cancer treatment.